Clinical Trial Update: MEtformin and Lorcaserin for WeighT Loss in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating metformin and lorcaserin for weight loss in schizophrenia; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Lorcaserin (lorcaserin)
• metformin (metformin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: TERMINATED | Results posted: 2021-02-05